1. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006; 110:525–541.
Article
2. Dietrich A, Hermans C, Heppt MV, Ruzicka T, Schauber J, Reinholz M. Human papillomavirus status, anal cytology and histopathological outcome in HIV-positive patients. J Eur Acad Dermatol Venereol. 2015; 29:2011–2018.
Article
3. Rosales R, Rosales C. Immune therapy for human papillomaviruses-related cancers. World J Clin Oncol. 2014; 5:1002–1019.
Article
4. Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012; 5:25–36.
5. Fallen RS, Gooderham M. Ingenol mebutate: an introduction. Skin Therapy Lett. 2012; 17:1–3.
6. Maier T, Braun-Falco M, Hinz T, Schmid-Wendtner MH, Ruzicka T, Berking C. Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology. J Eur Acad Dermatol Venereol. 2013; 27:e97–e104.
Article
7. Maier T, Braun-Falco M, Laubender RP, Ruzicka T, Berking C. Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol. 2013; 168:120–128.
Article
8. Reinholz M, Gauglitz GG, Giehl K, Braun-Falco M, Schwaiger H, Schauber J, et al. Non-invasive diagnosis of sweat gland dysplasia using optical coherence tomography and reflectance confocal microscopy in a family with anhidrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome). J Eur Acad Dermatol Venereol. 2016; 30:677–682.
Article
9. Maier T, Cekovic D, Ruzicka T, Sattler EC, Berking C. Treatment monitoring of topical ingenol mebutate in actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy: a case series. Br J Dermatol. 2015; 172:816–818.
Article
10. von Braunmühl T, Welzel J. [Noninvasive diagnostic imaging in dermatology]. Hautarzt. 2015; 66:492. German.
11. von Braunmühl T. [Optical coherence tomography]. Hautarzt. 2015; 66:499–503. German.
12. Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, et al. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol. 2009; 60:934–943.
Article
13. von Krogh G, Szpak E, Andersson M, Bergelin I. Self-treatment using 0.25%–0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebo-controlled comparative study. Genitourin Med. 1994; 70:105–109.
Article
14. Schöfer H, Van Ophoven A, Henke U, Lenz T, Eul A. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts. Eur J Dermatol. 2006; 16:642–648.
15. Gross G, Meyer KG, Pres H, Thielert C, Tawfik H, Mescheder A. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol. 2007; 21:1404–1412.
Article
16. Khawaja HT. Treatment of condyloma acuminatum. Lancet. 1986; 1:208–209.
Article
17. Khawaja HT. Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata: a prospective study. Br J Surg. 1989; 76:1067–1068.
Article
18. Braun SA, Jansen TM, Homey B, Gerber PA. [Successful therapy of condylomata acuminata with ingenol mebutate]. Hautarzt. 2015; 66:223–225. German.
Article
19. Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012; 66:486–493.
Article
20. Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, et al. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res. 2004; 64:2833–2839.